ES8407040A1 - Procedimiento para la obtencion de compuestos con nucleo heterociclico diazoado - Google Patents

Procedimiento para la obtencion de compuestos con nucleo heterociclico diazoado

Info

Publication number
ES8407040A1
ES8407040A1 ES528921A ES528921A ES8407040A1 ES 8407040 A1 ES8407040 A1 ES 8407040A1 ES 528921 A ES528921 A ES 528921A ES 528921 A ES528921 A ES 528921A ES 8407040 A1 ES8407040 A1 ES 8407040A1
Authority
ES
Spain
Prior art keywords
compounds
preparation
central nerve
nerve system
heterocyclic nucleus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES528921A
Other languages
English (en)
Other versions
ES528921A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES528921A0 publication Critical patent/ES528921A0/es
Publication of ES8407040A1 publication Critical patent/ES8407040A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Polymerisation Methods In General (AREA)
  • Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS CON NUCLEO HETEROCICLICO DIAZOADO Y DE SUS SALES CON ACIDOS FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE X1, X2, AR Y R5 PUEDEN SER VARIOS TIPOS DE RADICALES.CONSISTE EN LA TRANSFORMACION DE UN COMPUESTO DE FORMULA (I), EN LA QUE EL RADICAL X1 O X2 SE ENCUENTRA EN FORMA DE UNA CETONA, EN EL DERIVADO CLORADO CORRESPONDIENTE; SEGUIDA DE LA REACCION CON UNA AMINA DE FORMULA R1-NH-R2 EN LA QUE R1 Y R2 PUEDEN SER VARIOS RADICALES; EFECTUANDOSE AMBAS REACCIONES POR METODOS CONVENCIONALES.ESTOS COMPUESTOS TIENENAPLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD SOBRE EL SISTEMA NERVIOSO CENTRAL.
ES528921A 1983-01-21 1984-01-17 Procedimiento para la obtencion de compuestos con nucleo heterociclico diazoado Expired ES8407040A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8300954A FR2539741A1 (fr) 1983-01-21 1983-01-21 Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Publications (2)

Publication Number Publication Date
ES528921A0 ES528921A0 (es) 1984-09-01
ES8407040A1 true ES8407040A1 (es) 1984-09-01

Family

ID=9285183

Family Applications (1)

Application Number Title Priority Date Filing Date
ES528921A Expired ES8407040A1 (es) 1983-01-21 1984-01-17 Procedimiento para la obtencion de compuestos con nucleo heterociclico diazoado

Country Status (30)

Country Link
US (1) US4624952A (es)
EP (1) EP0114770B1 (es)
JP (1) JPS59137469A (es)
KR (1) KR910000640B1 (es)
AT (1) ATE28453T1 (es)
AU (1) AU563160B2 (es)
CA (1) CA1217490A (es)
CS (1) CS242894B2 (es)
DD (1) DD216014A5 (es)
DE (1) DE3464909D1 (es)
DK (1) DK25684A (es)
EG (1) EG16212A (es)
ES (1) ES8407040A1 (es)
FI (1) FI79537C (es)
FR (1) FR2539741A1 (es)
GR (1) GR79766B (es)
HU (1) HU191586B (es)
IE (1) IE56569B1 (es)
IL (1) IL70740A (es)
MA (1) MA20007A1 (es)
NO (1) NO159170C (es)
NZ (1) NZ206906A (es)
OA (1) OA07638A (es)
PH (1) PH21060A (es)
PL (1) PL143224B1 (es)
PT (1) PT77966B (es)
SG (1) SG2189G (es)
SU (1) SU1342415A3 (es)
YU (1) YU10384A (es)
ZA (1) ZA84342B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
DE3517617A1 (de) * 1985-05-15 1986-11-20 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US8575167B2 (en) * 2007-02-06 2013-11-05 Takeda Pharmaceutical Company Limited Spiro compounds having stearoyl-CoA desaturase action
CN107973791B (zh) * 2015-04-29 2020-04-07 南京圣和药业股份有限公司 稠环或三环芳基嘧啶化合物用作激酶抑制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
US4302455A (en) * 1980-04-14 1981-11-24 Merck & Co., Inc. 2-(4-Aminopiperidino)pyrazines
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2511366A1 (fr) * 1981-08-11 1983-02-18 Sanofi Sa Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Also Published As

Publication number Publication date
KR910000640B1 (ko) 1991-01-31
PT77966A (fr) 1984-02-01
JPS59137469A (ja) 1984-08-07
PL245836A1 (en) 1985-07-02
NO159170B (no) 1988-08-29
MA20007A1 (fr) 1984-10-01
DE3464909D1 (en) 1987-08-27
PH21060A (en) 1987-07-10
DK25684A (da) 1984-07-22
IL70740A (en) 1986-09-30
GR79766B (es) 1984-10-31
IE56569B1 (en) 1991-09-11
ATE28453T1 (de) 1987-08-15
CA1217490A (en) 1987-02-03
DD216014A5 (de) 1984-11-28
FR2539741A1 (fr) 1984-07-27
SG2189G (en) 1989-06-02
DK25684D0 (da) 1984-01-20
HU191586B (en) 1987-03-30
EG16212A (en) 1989-06-30
EP0114770A2 (fr) 1984-08-01
FI79537C (fi) 1990-01-10
IE840102L (en) 1984-07-21
FR2539741B1 (es) 1985-05-17
EP0114770B1 (en) 1987-07-22
CS242894B2 (en) 1986-05-15
SU1342415A3 (ru) 1987-09-30
YU10384A (en) 1986-10-31
ES528921A0 (es) 1984-09-01
IL70740A0 (en) 1984-04-30
FI840238A0 (fi) 1984-01-20
CS42484A2 (en) 1985-08-15
FI840238A (fi) 1984-07-22
NZ206906A (en) 1987-05-29
NO159170C (no) 1988-12-07
ZA84342B (en) 1984-08-29
NO840214L (no) 1984-07-23
PT77966B (fr) 1986-07-11
OA07638A (fr) 1985-05-23
PL143224B1 (en) 1988-01-30
KR840007406A (ko) 1984-12-07
AU563160B2 (en) 1987-07-02
AU2323684A (en) 1984-07-26
EP0114770A3 (en) 1984-08-22
FI79537B (fi) 1989-09-29
US4624952A (en) 1986-11-25

Similar Documents

Publication Publication Date Title
ES468378A1 (es) Procedimiento de preparacion de un derivado de acetamina.
ES8407040A1 (es) Procedimiento para la obtencion de compuestos con nucleo heterociclico diazoado
ES8800235A1 (es) Un procedimiento para preparar un isomero sin de un compues-to de cefem
FR2314192A1 (fr) Procede de preparation d'oxaphospholannes-1,2
ES2171389T3 (es) Derivados anticonvulsivos de aminoacidos.
ES8708134A1 (es) Un procedimiento para la preparacion de derivados de homocisteina-tiolactona
JPS5353687A (en) Production of lactam from cyclic oxime
JPS5236643A (en) Production of nnacyl derivatives of glycine substituted at alphaaposition by novel aromatic group
AU5165579A (en) Derivatives of n-substituted cyclic amines
FR2336377A1 (fr) Procede de preparation de la n-(3,4-dimethylphenyl)-d-ribamine
BE860921A (fr) Procede de preparation d'amines aromatiques
GB1539435A (en) Process for the manufacture of hexamethylene diamine
GR61184B (en) Preparation process of anthel minthic active,basic substituted 2-carbalkoxy amino-benzimidazolyl-5(6)-phenyl-ethers and-ketones
IL58021A (en) Microbiological process for the production of 3a -h-4 (3'-propionic acid)-5 -hydroxy-7a -methyl-hexahydro-1-indanone- -lactone
RO91934B1 (ro) Procedeu de obtinere a n-cloracetil-n-fenil-2,6-dicloranilinei
RO76082A (fr) Procede pour la preparation des anilines n-substitues
BE853667A (fr) Procede de preparation d'amines aromatiques

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203